Insider Transactions in Q3 2022 at Iterum Therapeutics PLC (ITRM)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
7,246
-100.0%
|
$7,246
$1.78 P/Share
|
|
Sep 19
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
15,000
-67.43%
|
$15,000
$1.77 P/Share
|
|
Sep 16
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
15,000
-40.27%
|
$15,000
$1.9 P/Share
|
|
Sep 15
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
15,000
-28.71%
|
$30,000
$2.02 P/Share
|
|
Sep 14
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
15,000
-22.31%
|
$30,000
$2.1 P/Share
|
|
Sep 13
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
15,000
-18.24%
|
$30,000
$2.14 P/Share
|
|
Sep 12
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
15,000
-15.42%
|
$30,000
$2.31 P/Share
|
|
Sep 09
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
15,000
-13.36%
|
$30,000
$2.32 P/Share
|
|
Sep 08
2022
|
Brenton Karl Ahrens Director |
SELL
Open market or private sale
|
Indirect |
3,298
-2.85%
|
$6,596
$2.26 P/Share
|
|
Sep 07
2022
|
Michael W. Dunne |
BUY
Open market or private purchase
|
Direct |
10,000
+21.94%
|
$20,000
$2.22 P/Share
|